Product Code: GVR-1-68038-576-2
Gene Expression Market Growth & Trends:
The global gene expression market size is anticipated to reach USD 20.94 billion by 2030, registering a CAGR of 5.0% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The market growth is being driven by various factors, such as advancements in genomic technologies like microarray analysis, quantitative polymerase chain reaction, and next-generation sequencing (NGS). The increasing adoption of precision medicine and the rising demand for personalized medicines also contribute significantly to this growth.
Genes are segments of DNA found within the genome that encode proteins. Different organisms possess genomes with thousands of different types of genes responsible for various functions. During different stages of cell development and physiological processes, including cell differentiation, these genes are precisely regulated and expressed. Gene expression can be influenced by environmental and stimuli factors, such as temperature, nutrients, hormones, and stress. Although the fundamental process of transcription, which involves producing mRNA from protein-coding genes, is similar across different organisms, the mechanisms of gene regulation and the molecular machinery involved can vary.
In the post-genomic and epigenomic era, it is increasingly recognized that gene expression is not solely controlled by gene sequences. Other non-genomic factors, including protein and DNA modifications, as well as non-coding RNAs, play significant roles in regulating gene expression. These factors contribute to the complexity of gene regulation and have implications for understanding the broader mechanisms that control cellular processes and development.
Gene Expression Market Report Highlights:
- cDNA synthesis & conversion segment accounted for the largest share of 27.1% in 2022. This is due to the development of new technologies and tools for cDNA synthesis and the increasing demand for genetic research.
- Based on the product, kits & reagents accounted for the largest share of 74.2% in 2022. The introduction of innovative products designed for specific uses drives the segment's growth.
- The high-plex segment is anticipated to register the fastest CAGR of 5.3% during the forecast period. Increased use of gene expression analysis for several genomic studies is the primary reason driving the growth of this segment.
- Drug discovery & development dominated the market with a revenue share of 42.2% in 2022.
- RNA expression accounted for the largest share of 41.7% in 2022. Technological advances in RNA expression tools and techniques, coupled with the availability of a range of products to meet different research needs, are anticipated to increase the adoption of these techniques for gene expression analysis.
- Asia Pacific is anticipated to witness the highest CAGR of 6.9% during the forecast time frame. Rising pharmaceutical and biotechnology activities in the region drive the growth of the market. Countries such as South Korea, Japan, India, and China have made substantial investments in R&D for gene expression studies.
Table of Contents
Chapter 1. Methodology And Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment Definitions
- 1.2. Regional Scope
- 1.3. Estimates And Forecast Timeline
- 1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective - 2
- 1.4.3. Objective - 3
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information Or Data Analysis
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.9.2. Parent Market Analysis
- 1.10. List Of Secondary Sources
- 1.11. List Of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Gene Expression Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Technological advances that enhance gene expression
- 3.2.1.2. High investment in genomic research
- 3.2.1.3. Increased focus on precision medicine
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Challenges in data analysis
- 3.2.2.2. High price of important instruments
- 3.3. Gene Expression Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Gene Expression Market: Process Estimates & Trend Analysis
- 4.1. Gene Expression Market: Process Movement Analysis
- 4.2. Sample Collection
- 4.2.1. Sample Collection Gene Expression Market, 2018 to 2030 (USD Million)
- 4.3. Purification
- 4.3.1. Purification Gene Expression Market, 2018 to 2030 (USD Million)
- 4.4. cDNA synthesis & conversion
- 4.4.1. cDNA synthesis & conversion Gene Expression Market, 2018 to 2030 (USD Million)
- 4.5. PCR Analysis
- 4.5.1. PCR Analysis Gene Expression Market, 2018 to 2030 (USD Million)
Chapter 5. Gene Expression Market: Product Estimates & Trend Analysis
- 5.1. Gene Expression Market: Product Movement Analysis
- 5.2. Kits & Reagents
- 5.2.1. Kits & Reagents Gene Expression Market, 2018 to 2030 (USD Million)
- 5.3. Manufacturing and Packaging
- 5.3.1. DNA chips Gene Expression Market, 2018 to 2030 (USD Million)
- 5.4. Others
- 5.4.1. Others Gene Expression Market, 2018 to 2030 (USD Million)
Chapter 6. Gene Expression Market: Capacity Estimates & Trend Analysis
- 6.1. Gene Expression Market: Capacity Movement Analysis
- 6.2. Low- to Mid- Plex
- 6.2.1. Low to Mid Plex Expression Market 2018 to 2030 (USD Million)
- 6.3. High-Plex
- 6.3.1. High-Plex Gene Expression Market 2018 to 2030 (USD Million)
Chapter 7. Gene Expression Market: Application Estimates & Trend Analysis
- 7.1. Gene Expression Market: Application Movement Analysis
- 7.2. Drug Discovery & Development
- 7.2.1. Drug Discovery & Development Market 2018 to 2030 (USD Million)
- 7.3. Clinical Diagnostics
- 7.3.1. Clinical Diagnostics Gene Expression Market 2018 to 2030 (USD Million)
- 7.4. Biotech & Microbiology
- 7.4.1. Biotech & Microbiology Gene Expression Market 2018 to 2030 (USD Million)
- 7.5. Others
- 7.5.1. Others Gene Expression Market 2018 to 2030 (USD Million)
Chapter 8. Gene Expression Market: Technique Estimates & Trend Analysis
- 8.1. Gene Expression Market: Technique Movement Analysis
- 8.2. RNA Expression
- 8.2.1. RNA Expression Gene Expression Market 2018 to 2030 (USD Million)
- 8.3. Promoter Analysis
- 8.3.1. Promoter Analysis Gene Expression Market 2018 to 2030 (USD Million)
- 8.4. Protein Expression & Posttranslational Modification Analysis
- 8.4.1. Protein Expression & Posttranslational Modification Analysis Gene Expression Market 2018 to 2030 (USD Million)
- 8.5. Others
- 8.5.1. Others Gene Expression Market 2018 to 2030 (USD Million)
Chapter 9. Gene Expression Market: Regional Estimates & Trend Analysis
- 9.1. Gene Expression: Regional Movement Analysis
- 9.2. North America
- 9.2.1. Market Gene Expression Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
- 9.2.2. U.S.
- 9.2.2.1. Key Country Dynamics
- 9.2.2.2. Competitive Scenario
- 9.2.2.3. Regulatory Framework
- 9.2.2.4. U.S. Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.2.3. Canada
- 9.2.3.1. Key Country Dynamics
- 9.2.3.2. Competitive Scenario
- 9.2.3.3. Regulatory Framework
- 9.2.3.4. Canada Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.3. Europe
- 9.3.1. Europe Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.3.2. UK
- 9.3.2.1. Key Country Dynamics
- 9.3.2.2. Competitive Scenario
- 9.3.2.3. Regulatory Framework
- 9.3.2.4. UK Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.3.3. Germany
- 9.3.3.1. Key Country Dynamics
- 9.3.3.2. Competitive Scenario
- 9.3.3.3. Regulatory Framework
- 9.3.3.4. Germany Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.3.4. France
- 9.3.4.1. Key Country Dynamics
- 9.3.4.2. Competitive Scenario
- 9.3.4.3. Regulatory Framework
- 9.3.4.4. France Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.3.5. Italy
- 9.3.5.1. Key Country Dynamics
- 9.3.5.2. Competitive Scenario
- 9.3.5.3. Regulatory Framework
- 9.3.5.4. Italy Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.3.6. Spain
- 9.3.6.1. Key Country Dynamics
- 9.3.6.2. Competitive Scenario
- 9.3.6.3. Regulatory Framework
- 9.3.6.4. Spain Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.3.7. Denmark
- 9.3.7.1. Key Country Dynamics
- 9.3.7.2. Competitive Scenario
- 9.3.7.3. Regulatory Framework
- 9.3.7.4. Denmark Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.3.8. Sweden
- 9.3.8.1. Key Country Dynamics
- 9.3.8.2. Competitive Scenario
- 9.3.8.3. Regulatory Framework
- 9.3.8.4. Sweden Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.3.9. Norway
- 9.3.9.1. Key Country Dynamics
- 9.3.9.2. Competitive Scenario
- 9.3.9.3. Regulatory Framework
- 9.3.9.4. Norway Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.4. Asia Pacific
- 9.4.1. Asia Pacific Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.4.2. Japan
- 9.4.2.1. Key Country Dynamics
- 9.4.2.2. Competitive Scenario
- 9.4.2.3. Regulatory Framework
- 9.4.2.4. Japan Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.4.3. India
- 9.4.3.1. Key Country Dynamics
- 9.4.3.2. Competitive Scenario
- 9.4.3.3. Regulatory Framework
- 9.4.3.4. India Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.4.4. China
- 9.4.4.1. Key Country Dynamics
- 9.4.4.2. Competitive Scenario
- 9.4.4.3. Regulatory Framework
- 9.4.4.4. China Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.4.5. South Korea
- 9.4.5.1. Key Country Dynamics
- 9.4.5.2. Competitive Scenario
- 9.4.5.3. Regulatory Framework
- 9.4.5.4. South Korea Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.4.6. Australia
- 9.4.6.1. Key Country Dynamics
- 9.4.6.2. Competitive Scenario
- 9.4.6.3. Regulatory Framework
- 9.4.6.4. Australia Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.4.7. Thailand
- 9.4.7.1. Key Country Dynamics
- 9.4.7.2. Competitive Scenario
- 9.4.7.3. Regulatory Framework
- 9.4.7.4. Thailand Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.5. Latin America
- 9.5.1. Latin America Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.5.2. Brazil
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. Competitive Scenario
- 9.5.2.3. Regulatory Framework
- 9.5.2.4. Brazil Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.5.3. Mexico
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Competitive Scenario
- 9.5.3.3. Regulatory Framework
- 9.5.3.4. Mexico Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.5.4. Argentina
- 9.5.4.1. Key Country Dynamics
- 9.5.4.2. Competitive Scenario
- 9.5.4.3. Regulatory Framework
- 9.5.4.4. Argentina Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.6. MEA
- 9.6.1. MEA Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.6.2. South Africa
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Competitive Scenario
- 9.6.2.3. Regulatory Framework
- 9.6.2.4. South Africa Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.6.3. Saudi Arabia
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. Competitive Scenario
- 9.6.3.3. Regulatory Framework
- 9.6.3.4. Saudi Arabia Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.6.4. UAE
- 9.6.4.1. Key Country Dynamics
- 9.6.4.2. Competitive Scenario
- 9.6.4.3. Regulatory Framework
- 9.6.4.4. UAE Gene Expression Market Estimates and Forecasts, 2018 - 2030
- 9.6.5. Kuwait
- 9.6.5.1. Key Country Dynamics
- 9.6.5.2. Competitive Scenario
- 9.6.5.3. Regulatory Framework
- 9.6.5.4. Kuwait Gene Expression Market Estimates and Forecasts, 2018 - 2030
Chapter 10. Competitive Landscape
- 10.1. Market Participant Categorization
- 10.1.1. Innovators
- 10.1.2. Market Leaders
- 10.1.3. Emerging Players
- 10.1.4. Company Market Share Analysis, 2022
- 10.2. Company Profiles
- 10.2.1. Qiagen
- 10.2.1.1. Company Overview
- 10.2.1.2. Financial Performance
- 10.2.1.3. Service Benchmarking
- 10.2.1.4. Strategic Initiatives
- 10.2.2. Quest Diagnostics Incorporated
- 10.2.2.1. Company Overview
- 10.2.2.2. Financial Performance
- 10.2.2.3. Service Benchmarking
- 10.2.2.4. Strategic Initiatives
- 10.2.3. F. Hoffmann-La Roche Ltd
- 10.2.3.1. Company Overview
- 10.2.3.2. Financial Performance
- 10.2.3.3. Service Benchmarking
- 10.2.3.4. Strategic Initiatives
- 10.2.4. Illumina, Inc.
- 10.2.4.1. Company Overview
- 10.2.4.2. Financial Performance
- 10.2.4.3. Service Benchmarking
- 10.2.4.4. Strategic Initiatives
- 10.2.5. Bio-Rad Laboratories, Inc.
- 10.2.5.1. Company Overview
- 10.2.5.2. Financial Performance
- 10.2.5.3. Service Benchmarking
- 10.2.5.4. Strategic Initiatives
- 10.2.6. Thermo Fisher Scientific, Inc.
- 10.2.6.1. Company Overview
- 10.2.6.2. Financial Performance
- 10.2.6.3. Service Benchmarking
- 10.2.6.4. Strategic Initiatives
- 10.2.7. Promega Corporation
- 10.2.7.1. Company Overview
- 10.2.7.2. Financial Performance
- 10.2.7.3. Service Benchmarking
- 10.2.7.4. Strategic Initiatives
- 10.2.8. Danaher
- 10.2.8.1. Company Overview
- 10.2.8.2. Financial Performance
- 10.2.8.3. Service Benchmarking
- 10.2.8.4. Strategic Initiatives
- 10.2.9. Interpace Diagnostics, LLC.
- 10.2.9.1. Company Overview
- 10.2.9.2. Financial Performance
- 10.2.9.3. Service Benchmarking
- 10.2.9.4. Strategic Initiatives
- 10.2.10. Luminex Corporation
- 10.2.10.1. Company Overview
- 10.2.10.2. Financial Performance
- 10.2.10.3. Service Benchmarking
- 10.2.10.4. Strategic Initiatives